TDC
ELV icon

Thompson Davis & Co’s Elevance Health ELV Stock Holding History

Thompson Davis & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$30K Buy
109
+1
+0.9% +$260 0.07% 277
2018
Q2 		$26K Hold
108
– – 0.06% 277
2018
Q1 		$24K Hold
108
– – 0.06% 270
2017
Q4 		$24K Buy
108
+1
+0.9% +$213 0.06% 294
2017
Q3 		$20K Hold
107
– – 0.04% 481
2017
Q2 		$20K Sell
107
-399
-79% -$71.7K 0.03% 463
2017
Q1 		$84K Hold
506
– – 0.12% 166
2016
Q4 		$73K Hold
506
– – 0.12% 180
2016
Q3 		$63K Buy
506
+1
+0.2% +$129 0.11% 195
2016
Q2 		$66K Buy
505
+400
+381% +$54.7K 0.11% 190
2016
Q1 		$15K Sell
105
-70
-40% -$9.35K 0.02% 535
2015
Q4 		$24K Sell
175
-3
-2% -$413 0.03% 413
2015
Q3 		$25K Buy
178
+1
+0.6% +$150 0.04% 397
2015
Q2 		$29K Sell
177
-61
-26% -$9.75K 0.03% 434
2015
Q1 		$37K Sell
238
-69
-22% -$9.82K 0.04% 361
2014
Q4 		$39K Sell
307
-63
-17% -$7.79K 0.05% 331
2014
Q3 		$44K Buy
370
+268
+263% +$30.7K 0.06% 286
2014
Q2 		$11K Buy
102
+1
+1% +$103 0.02% 474
2014
Q1 		$10K Buy
+101
New +$9.13K 0.02% 485

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thompson Davis & Co's ELV Position: Q3 2018 in Review

Thompson Davis & Co increased its Elevance Health (ELV) stake by 0.93% in Q3 2018, buying an estimated $260 and bringing the position to 109 shares worth $30K. The position accounts for 0.07% of the portfolio, ranked #277.

Thompson Davis & Co first reported a position in ELV in Q1 2014 and has held it in 19 quarters since. The position peaked at $84K in Q1 2017. 947 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Thompson Davis & Co held 109 shares of Elevance Health worth $30K as of Q3 2018.
  • Thompson Davis & Co bought 1 Elevance Health share in Q3 2018, an estimated $260.
  • Elevance Health made up 0.07% of Thompson Davis & Co's portfolio in Q3 2018, its #277 holding.
  • Thompson Davis & Co first reported a position in Elevance Health in Q1 2014 and has held it in 19 quarters since.
  • Thompson Davis & Co's Elevance Health position peaked at $84K in Q1 2017.
  • 947 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.